Concepedia

H. Ümit Kanıskan

HÜ

Statistics

Publications

48

Citations

3.5K

H-Index

31

Active since

2005

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of North Carolina at Chapel Hill

Harvard University

Structural Genomics Consortium

Beth Israel Deaconess Medical Center

H. Ümit Kanıskan is an author at Icahn School of Medicine at Mount Sinai specializing in molecular oncology, life sciences, and molecular biology.

ORCID

Publications per year

2005–2025

48

Publications

48

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Mohammad S. Eram, Yudao Shen, Magdalena M. Szewczyk et al. · ACS Chemical Biology · 2015 · 292 citations · Full text

, , +5

Cancer Selective Target Degradation by Folate-Caged PROTACs

Jing Liu, He Chen, Yi Liu et al. · Journal of the American Chemical Society · 2021 · 288 citations · Full text

, , +15

Light-induced control of protein destruction by opto-PROTAC

Jing Liu, He Chen, Leina Ma et al. · Science Advances · 2020 · 278 citations · Full text

, , +12

TF-PROTACs Enable Targeted Degradation of Transcription Factors

Jing Liu, He Chen, H. Ümit Kanıskan et al. · Journal of the American Chemical Society · 2021 · 233 citations · Full text

, , +13

Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s Disease

Minghui Wang, Aiqun Li, Michiko Sekiya et al. · Neuron · 2020 · 212 citations · Full text

, , +17

1–5 of 48